Conversely, in the tumor microenvironment, chronic antigen exposure under Th2 (IL-4/IL-13) and IL-10 signaling drives local IgG4 production, which correlates with poor prognosis in malignancies such as melanoma and cholangiocarcinoma. This evidence concerns the gene IL10 and neoplasm.